This bill amends existing legislation regarding the administration of epinephrine in schools during emergencies related to anaphylaxis. It expands the mechanisms permitted for administering epinephrine from solely using a pre-filled auto-injector to allowing any FDA approved mechanism. The bill outlines that each board of education or chief school administrator must develop a policy that includes obtaining written authorization from parents or guardians, ensuring that the school nurse or trained designees are available to administer the medication, and maintaining a supply of FDA approved epinephrine administration devices. Additionally, it emphasizes that the school and its employees will not be held liable for any injuries resulting from the administration of epinephrine.

Furthermore, the bill stipulates that the school nurse has primary responsibility for administering epinephrine and can designate additional trained employees to do so when the nurse is not present. It also requires that parents or guardians provide written consent for the administration of epinephrine and acknowledges the school's liability limitations. The changes aim to enhance the safety and responsiveness of schools in managing anaphylactic emergencies by broadening the options for epinephrine administration and ensuring proper training and protocols are in place.

Statutes affected:
Introduced: 18A:40-12.5, 18A:40-12.6